Cargando…
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
Over the past two years, several variants of SARS-CoV-2 have emerged and spread all over the world. However, infectivity, clinical severity, re-infection, virulence, transmissibility, vaccine responses and escape, and epidemiological aspects have differed between SARS-CoV-2 variants. Currently, very...
Autores principales: | Delandre, Océane, Gendrot, Mathieu, Jardot, Priscilla, Le Bideau, Marion, Boxberger, Manon, Boschi, Céline, Fonta, Isabelle, Mosnier, Joel, Hutter, Sébastien, Levasseur, Anthony, La Scola, Bernard, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024598/ https://www.ncbi.nlm.nih.gov/pubmed/35455442 http://dx.doi.org/10.3390/ph15040445 |
Ejemplares similares
-
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021) -
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Methylene blue inhibits replication of SARS-CoV-2 in vitro
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
por: Gendrot, Mathieu, et al.
Publicado: (2020)